What is the treatment approach for Henoch-Schönlein purpura?

What is the treatment approach for Henoch-Schönlein purpura?

• A. Immediate surgery
• B. Self-limited course
• C. Long-term antibiotic therapy
• D. Daily corticosteroids

Answer: (B)

Henoch-Schönlein purpura (HSP) is a small-vessel vasculitis that primarily affects children, characterized by a tetrad of symptoms: purpura, typically on the buttocks and legs, joint pain, abdominal pain, and renal involvement. The treatment approach is largely supportive, as HSP often follows a self-limited course. Patients typically experience resolution of symptoms within weeks to months without necessitating aggressive interventions. In many cases, supportive care includes pain management and monitoring for any complications, particularly concerning the kidneys. While corticosteroids may be used in severe cases or if there's significant abdominal pain, they are not routinely required for most patients, further underscoring the self-limiting nature of the condition. Surgery is not indicated as a treatment for HSP, as the condition often resolves spontaneously. Long-term antibiotic therapy is unnecessary, as HSP is not caused by an infection, and daily corticosteroids are not a standard treatment regimen, as they do not significantly alter the course of the disease for most patients. Therefore, the most accurate approach to managing Henoch-Schönlein purpura is recognizing its self-limited nature.

Henoch-Schönlein purpura (HSP) is a small-vessel vasculitis that primarily affects children, characterized by a tetrad of symptoms: purpura, typically on the buttocks and legs, joint pain, abdominal pain, and renal involvement. The treatment approach is largely supportive, as HSP often follows a self-limited course.

Patients typically experience resolution of symptoms within weeks to months without necessitating aggressive interventions. In many cases, supportive care includes pain management and monitoring for any complications, particularly concerning the kidneys. While corticosteroids may be used in severe cases or if there's significant abdominal pain, they are not routinely required for most patients, further underscoring the self-limiting nature of the condition.

Surgery is not indicated as a treatment for HSP, as the condition often resolves spontaneously. Long-term antibiotic therapy is unnecessary, as HSP is not caused by an infection, and daily corticosteroids are not a standard treatment regimen, as they do not significantly alter the course of the disease for most patients. Therefore, the most accurate approach to managing Henoch-Schönlein purpura is recognizing its self-limited nature.